EMD p.Arg168Cys
c.502C>T · rs886044839 · VCV285132
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1923 | likely benign |
|---|---|---|
| REVEL | 0.663 | pathogenic-leaning |
| SaProt | LLR -11.48 | damaging |
| ⇒ REVEL and SaProt call this damaging; AlphaMissense does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.6 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 1,709 bp · p 0.47 · regional, not allelic |
| Overall | ||
| CADD | 25.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0193% | 5,183 |
| East Asian | 0.00296% | 33,839 |
| Remaining individualsnot grpmax-eligible | 0.0021% | 47,646 |
| European (non-Finnish) | 0.000335% | 298,489 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- EMD
- Protein
- p.Arg168Cys
- Coding
- c.502C>T
- MANE Select
- NM_000117
- dbSNP
- rs886044839
- Type
- single nucleotide variant
- Location
- chrX:154380934 (GRCh38)
- Structure
- AlphaFold pLDDT 61.26 · 6 PDB
- Residue 168
- the 'interaction with f-actin' region; the 'interaction with ctnnb1' region
Similar variants
- EMD p.Arg168His Uncertain significance ★ ⚠ same residue
- EMD p.Arg168Leu Uncertain significance ★ ⚠ same residue
- EMD p.Arg168= Likely benign ★ same residue
- EMD c.187+1G>A Pathogenic ★★ same condition
- EMD c.187+1G>T Pathogenic/Likely pathogenic ★★ same condition
- EMD c.265+1G>A Likely pathogenic ★★ same condition
- EMD c.266-2A>G Pathogenic ★★ same condition
- EMD c.266-3A>G Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/emd-p-arg168cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown